ATX01, a new topical treatment for chemotherapy-induced peripheral neuropathy, will be investigated in a phase 2 trial. Researchers recently initiated a phase 2 clinical trial evaluating ATX01 ...

New drugs to prevent oxaliplatin-induced peripheral neuropathy: A double-blind, randomized study. Authors: Takeshi Yamada, Kensei Yamaguchi, Taishi Hata, Atsushi Ishiguro, Yoshinori Munemoto, Masataka ...

Clearance of the New Drug Application for ART25.12 allows Artelo to begin a Phase I study for the drug in chemotherapy-induced peripheral neuropathy. The FDA has granted clearance to Artelo ...

The dual GIP–GLP-1 receptor agonist tirzepatide that has shown significant benefits in diabetes and obesity may also help prevent diabetic peripheral neuropathy, new research suggests.

Peripheral neuropathy is common among people with diabetes. ... It is always a good idea to talk with a doctor before taking any new medications.

The global peripheral neuropathy treatment market is projected to achieve significant growth, with an increase of USD 481.6 million Key drivers include increased prevalence, new drug approvals ...

Peripheral neuropathy is a troubling side effect of certain chemotherapy drugs, known as taxanes, that are commonly used to ...

Human dorsal root ganglia in a case of diabetic peripheral neuropathy show formation of Nageotte nodules (circled in pink), which appear to be a strong indicator of nerve cell death. A phenomenon ...

Many with peripheral neuropathy use medications like Gabapentin, Lyrica, or Cymbalta for relief, but these only mask symptoms instead of treating the cause. While they may temporarily reduce pain ...

This surprising insight, published in Nature, could lead to strategies to prevent peripheral neuropathy or at least minimize and slow the onset of the damage. Immune cells prevent nerve damage ...

Peripheral neuropathy can cause numbness, tingling, ... the Food and Drug Administration ... You should always discuss new products with a healthcare professional and thoroughly research the brand ...

A new study has found evidence that vitamin D supplements may reduce chemotherapy-induced neuropathy (CIPN) in people with low levels of the vitamin.. Peripheral neuropathy is often described as ...